📖

DAOIBplusAO Phase 2 (NCT06467539) - Novel Antioxidant Augmentation for Early Dementia

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-daoib-plus-ao-nct06
Related Entities
clinical-trials-daoib-plus-ao-nct06467539
Metadata
slugclinical-trials-daoib-plus-ao-nct06467539
entity_typeclinical
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (52)
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Phase-Separated Organelle Targeting50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%
related🔬Synaptic pruning by microglia in early AD50%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%
related🧪SASP-Mediated Cholinergic Synapse Disruption50%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
related🧪Trans-Synaptic Adhesion Molecule Modulation50%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease44%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬Synaptic pruning by microglia in early AD40%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪Phase-Separated Organelle Targeting40%

💬 Discussion